Lepu Biopharma Co., Ltd.
Clinical trials sponsored by Lepu Biopharma Co., Ltd., explained in plain language.
-
New hope for advanced pancreatic cancer: phase 3 trial launches
Disease control Not yet recruitingThis phase 3 study tests whether adding the experimental drug MRG004A to standard supportive care helps people with advanced pancreatic cancer live longer. About 231 adults whose cancer has not responded to prior treatments will receive either MRG004A or a placebo, along with bes…
Phase: PHASE3 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 01:46 UTC
-
New hope for advanced liver cancer: experimental combo therapy enters human trials
Disease control Not yet recruitingThis study tests a new drug called MRG006A combined with standard immunotherapy and targeted therapy for people with advanced liver cancer that cannot be removed by surgery. The goal is to find a safe dose and see if the combination helps control the cancer. About 160 adults with…
Phase: PHASE1, PHASE2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated May 12, 2026 13:39 UTC